In particular, endothelial incubation with SSc-ICs modulates several molecules involved in the three cardinal scleroderma pathophysiologic processes: vascular dysfunction (ET-1 and IL-8), inflammation (ICAM-1, IL-6), and fibrosis (TGF-β1). This evidence concerns the gene ICAM1 and systemic sclerosis.